Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DS5361b |
| Synonyms | |
| Therapy Description |
Limited information is currently available on DS5361b (Sep 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DS5361b | DS5 361b|DS5-361b | Limited information is currently available on DS5361b (Sep 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07182591 | Phase I | DS5361b + Pembrolizumab DS5361b | A Study of DS5361b in Participants With Advanced Solid Tumors | Recruiting | USA | 0 |